EC Healthcare to Gain Full Control of Target Company after HK$6.00 Million Put-Option Exercise

Bulletin Express04-21

On 21 April 2026, EC Healthcare announced that the seller of its minority interest in the unnamed Target Company has exercised a previously granted put option, requiring EC Healthcare’s indirect wholly owned subsidiary (the Purchaser) to acquire the seller’s remaining 10% stake.

The put-option exercise price is HK$6.00 million, calculated with reference to the FY25 Cash EBITDA agreed by both parties. EC Healthcare will fund the payment entirely through internal resources.

Following completion, the Target Company will become a wholly owned subsidiary of EC Healthcare. The group confirms that the transaction will not affect the Target Company’s existing business or operations, and the entity will continue to be consolidated into EC Healthcare’s financial statements.

The put-option exercise complies with Rule 14.74(2) of the Hong Kong Listing Rules. The board of EC Healthcare, chaired by Executive Director Mr. Tang Chi Fai, approved the related announcement released on 21 April 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1106977177?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-21 18:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1106977177","market":"hk","top_or_hot":-1,"title":"EC Healthcare to Gain Full Control of Target Company after HK$6.00 Million Put-Option Exercise","media":"Bulletin Express","content":"<p>On 21 April 2026, EC Healthcare announced that the seller of its minority interest in the unnamed Target Company has exercised a previously granted put option, requiring EC Healthcare’s indirect wholly owned subsidiary (the Purchaser) to acquire the seller’s remaining 10% stake.</p>\n<p>The put-option exercise price is HK$6.00 million, calculated with reference to the FY25 Cash EBITDA agreed by both parties. EC Healthcare will fund the payment entirely through internal resources.</p>\n<p>Following completion, the Target Company will become a wholly owned subsidiary of EC Healthcare. The group confirms that the transaction will not affect the Target Company’s existing business or operations, and the entity will continue to be consolidated into EC Healthcare’s financial statements.</p>\n<p>The put-option exercise complies with Rule 14.74(2) of the Hong Kong Listing Rules. The board of EC Healthcare, chaired by Executive Director Mr. Tang Chi Fai, approved the related announcement released on 21 April 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EC Healthcare to Gain Full Control of Target Company after HK$6.00 Million Put-Option Exercise</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEC Healthcare to Gain Full Control of Target Company after HK$6.00 Million Put-Option Exercise\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-21 18:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On 21 April 2026, EC Healthcare announced that the seller of its minority interest in the unnamed Target Company has exercised a previously granted put option, requiring EC Healthcare’s indirect wholly owned subsidiary (the Purchaser) to acquire the seller’s remaining 10% stake.</p>\n<p>The put-option exercise price is HK$6.00 million, calculated with reference to the FY25 Cash EBITDA agreed by both parties. EC Healthcare will fund the payment entirely through internal resources.</p>\n<p>Following completion, the Target Company will become a wholly owned subsidiary of EC Healthcare. The group confirms that the transaction will not affect the Target Company’s existing business or operations, and the entity will continue to be consolidated into EC Healthcare’s financial statements.</p>\n<p>The put-option exercise complies with Rule 14.74(2) of the Hong Kong Listing Rules. The board of EC Healthcare, chaired by Executive Director Mr. Tang Chi Fai, approved the related announcement released on 21 April 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02138","symbol_name":"医思健康","start_time":0,"source_url":"","article_id":"1106977177","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1106977177","pubTimestamp":1776765978,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"On 21 April 2026, EC Healthcare announced that the seller of its minority interest in the unnamed Target Company has exercised a previously granted put option, requiring EC Healthcare’s indirect...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02138":"医思健康"},"translate_title":"EC Healthcare于行使600万港元认沽期权后获得目标公司的全部控制权","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02138":1},"content_text":"On 21 April 2026, EC Healthcare announced that the seller of its minority interest in the unnamed Target Company has exercised a previously granted put option, requiring EC Healthcare’s indirect wholly owned subsidiary (the Purchaser) to acquire the seller’s remaining 10% stake.\nThe put-option exercise price is HK$6.00 million, calculated with reference to the FY25 Cash EBITDA agreed by both parties. EC Healthcare will fund the payment entirely through internal resources.\nFollowing completion, the Target Company will become a wholly owned subsidiary of EC Healthcare. The group confirms that the transaction will not affect the Target Company’s existing business or operations, and the entity will continue to be consolidated into EC Healthcare’s financial statements.\nThe put-option exercise complies with Rule 14.74(2) of the Hong Kong Listing Rules. The board of EC Healthcare, chaired by Executive Director Mr. Tang Chi Fai, approved the related announcement released on 21 April 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1106977177","isCrawlerRequest":true}